IGF1 and type 2 diabetes mellitus: The results of this study suggest that the use of T2DM ADSCs in regenerative treatments helps to reduce regeneration efficiencies, and the reduction in the expression levels of G6PC3 and IGF1 genes has the potential to improve transplantation efficiencies.